Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Danaher; Sequenom; Agilent Technologies, BIO5 Institute; University of Colorado; University of Michigan

NEW YORK (GenomeWeb News) – Danaher this week said that its board of directors has approved a quarterly dividend of $.025 per share payable on Oct. 28, to shareholders of record on Sept. 30.

A US District judge has sentenced two brothers found guilty of conspiring to trade Sequenom stock options using insider information to three years of probation. The brothers, patent agent Aaron Scalia, and his brother, Stephen Scalia, pleaded guilty to insider trading earlier this year. Aaron Scalia was also ordered to spend four months in a halfway house, pay restitution of $185,000, and perform community service.

Agilent Technologies this week said that it will collaborate with Shane Snyder of the University of Arizona's BIO5 Institute on ways to detect contaminants in water including pharmaceuticals, personal care products, and other substances.

The University of Colorado Board of Regents this week unanimously approved the creation of the system-wide CU Biofrontiers Institute. The institute, which evolved from the Colorado Initiative in Molecular Biotechnology, is led by Nobel Laureate Thomas Cech. The new institute will bring together faculty members across many disciplines at the university, including chemistry, biochemistry, computational biology, molecular biology, applied mathematics, evolutionary biology, physics, engineering, and others.

The University of Michigan Medical School said this week that it will be one of the first medical schools in the country to establish a comprehensive Computational Medicine and Bioinformatics Department, following approval by its Board of Regents. According to UM, around 15 US colleges have academic departments for bioinformatics, computational biology, or clinical informatics, or bioinformatics. Its medical school will bring these related areas together in a single department and build on its existing institution, the U-M Center for Computational Medicine and Bioinformatics.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.